The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis

Bryna S. M. Chow, Christine Koulis, Pooja Krishnaswamy, Ulrike M. Steckelings, Thomas Unger, Mark E. Cooper, Karin A. Jandeleit-Dahm, Terri J. Allen*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

INIS